Impact of neoadjuvant chemotherapy on axillary nodal involvement in patients with clinically node negative triple negative breast cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9098|111|2|198-202

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.111, Iss.2, 2015-02, pp. : 198-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of neoadjuvant chemotherapy on pathologic axillary nodal status in HER‐2 positive patients presenting with clinically node‐negative disease

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 5, 2015-12 ,pp. : 453-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Relevance of Prognostic Factors in Axillary Node-Negative Breast Cancer

By  

Oncology Research and Treatment, Vol. 26, Iss. 5, 2003-11 ,pp. : 438-445

Karger

Access to resources Recommend Favorite

Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer

By  

Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. : 93-100

Bentham Science Publishers

Access to resources Recommend Favorite

Triple-negative breast cancer

By Bartsch Rupert  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 7-8, 2010-04 ,pp. : 174-181

Springer Publishing Company

Access to resources Recommend Favorite

CT‐Guided Wire Localization for Involved Axillary Lymph Nodes After Neo‐adjuvant Chemotherapy in Patients With Initially Node‐Positive Breast Cancer

By  

THE BREAST JOURNAL, Vol. 22, Iss. 4, 2016-07 ,pp. : 390-396

John Wiley & Sons Inc

Access to resources Recommend Favorite